Alkermes plc (NASDAQ:ALKS)

Stock Price: $29.51
+0.23 (0.79%)
Updated Jun 2, 2023 08:00 PM GMT+0000
Featured app
eToro
Invest now

77% of retail CFD accounts lose money.

Overview
Financials
Statistics
Profile
Chart
Market Cap 4.90B
Revenue 1.12B
Gross Profit 899.72M
Shares Out 166.12M
EPS (ttm) -1
PE Ratio -29.8537
Forward PE 319.7183
Dividend Rate (ttm) 0.0000
Dividend Yield 0.0000
Trading Day Jun 2
Last Price $29.51
Previous Close $29.28
Change ($) 0.23
Change (%) 0.79%
Day's Open 29.4
Day's Range 28.93 - 29.57
Day's Volume 0.99M
52 Week Range 21.75 - 32.23

About Alkermes plc

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis.

headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

News

No news found.

Quick info

Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
2,211
CEO
Richard F. Pops
Website
alkermes.com
Ticker Symbol
ALKS
Reporting Currency
USD